Concepedia

Publication | Closed Access

SKLB1002, a Novel Potent Inhibitor of VEGF Receptor 2 Signaling, Inhibits Angiogenesis and Tumor Growth <i>In Vivo</i>

DOI

101

Citations

30

References

2011

Year

Shuang Zhang, Zhixing Cao, Hongwei Tian, Guobo Shen, Yongping Ma, Huanzhang Xie, Yalin Liu, Chengjian Zhao, Senyi Deng, Yang Yang,
Clinical Cancer Research

Abstract

Our findings suggest that SKLB1002 inhibits angiogenesis and may be a potential drug candidate in anticancer therapy.

References

YearCitations

Page 1